Colony Group LLC Novo Cure LTD Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Colony Group LLC holds 89,926 shares of NVCR stock, worth $2.77 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

89,926

Previous 92,753 3.05%

Holding current value

$2.77 Million

Previous $3.85 Million 62.28%

% of portfolio

0.02%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $45,656 - $119,723	-2,827 Reduced 3.05%	89,926 $1.45 Million
Q2 2023 Aug 15, 2023	BUY	$40.29 - $82.51 $3.58 Million - $7.33 Million	88,821 Added 2258.93%	92,753 $3.85 Million
Q1 2023 May 16, 2023	SELL	$56.44 - $118.81 $5.63 Million - $11.9 Million	-99,831 Reduced 96.21%	3,932 $236,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $765,840 - $1.02 Million	11,970 Added 13.04%	103,763 $7.61 Million
Q3 2022 Nov 15, 2022	SELL	$67.99 - $89.57 $20,600 - $27,139	-303 Reduced 0.33%	91,793 $6.97 Million
Q2 2022 Aug 16, 2022	BUY	$56.6 - $89.9 $246,040 - $390,795	4,347 Added 4.95%	92,096 $6.4 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $311,637 - $437,898	5,181 Added 6.27%	87,749 $7.27 Million
Q4 2021 Feb 15, 2022	BUY	$75.08 - $121.99 $59,012 - $95,884	786 Added 0.96%	82,568 $6.2 Million
Q3 2021 Nov 17, 2021	SELL	$116.17 - $194.55 $772,646 - $1.29 Million	-6,651 Reduced 7.52%	81,782 $9.5 Million
Q2 2021 Aug 18, 2021	SELL	$130.4 - $225.58 $752,799 - $1.3 Million	-5,773 Reduced 6.13%	88,433 $19.6 Million
Q1 2021 May 21, 2021	SELL	$124.11 - $190.17 $516,794 - $791,867	-4,164 Reduced 4.23%	94,206 $12.5 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $346,350 - $537,744	-3,088 Reduced 3.04%	98,370 $17 Million
Q3 2020 Nov 17, 2020	SELL	$58.05 - $111.31 $280,091 - $537,070	-4,825 Reduced 4.54%	101,458 $11.3 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $247,447 - $321,897	-4,326 Reduced 3.91%	106,283 $6.3 Million
Q1 2020 May 18, 2020	SELL	$57.05 - $95.75 $249,308 - $418,427	-4,370 Reduced 3.8%	110,609 $7.45 Million
Q4 2019 Feb 18, 2020	SELL	$68.3 - $93.8 $253,256 - $347,810	-3,708 Reduced 3.12%	114,979 $9.69 Million
Q3 2019 Nov 26, 2019	SELL	$61.86 - $97.8 $1.23 Million - $1.95 Million	-19,940 Reduced 14.38%	118,687 $8.88 Million
Q2 2019 Aug 19, 2019	BUY	$42.22 - $63.23 $5.85 Million - $8.77 Million	138,627 New	138,627 $8.77 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account